Related references
Note: Only part of the references are listed.Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects
Arash Arashkia et al.
REVIEWS IN MEDICAL VIROLOGY (2021)
Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine
Rafael Dal-Re et al.
ANNALS OF INTERNAL MEDICINE (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
Ebenezer Tumban
VIRUSES-BASEL (2021)
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective
Colin D. Funk et al.
VIRUSES-BASEL (2021)
Acceptability of a COVID-19 Vaccine among the Saudi Population
Eman Ibrahim Alfageeh et al.
VACCINES (2021)
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni et al.
LANCET INFECTIOUS DISEASES (2021)
A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective
Wedad Saeed Al-Qahtani et al.
VACCINES (2021)
Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low-and Middle-Income Countries
Suzanna Awang Bono et al.
VACCINES (2021)
Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study
Nagla A. El-Shitany et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
Abdullah A. Algaissi et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
M. Sreepadmanabh et al.
JOURNAL OF BIOSCIENCES (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
COVID VACCINES: WHAT SCIENTISTS NOW WANT TO KNOW
Heidi Ledford et al.
NATURE (2020)
Vaccine hesitancy An overview
Eve Dube et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
New Decade of Vaccines 5 Addressing the vaccine confidence gap
Heidi J. Larson et al.
LANCET (2011)